| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $85.2M | +38.1% |
| SG&A Expense | $25.6M | +2.1% |
| Operating Income | -$110.8M | -20.7% |
| Income Tax | $0 | — |
| Net Income | -$100.7M | -13.0% |
| EPS (Basic) | -$1.96 | +12.9% |
| EPS (Diluted) | -$1.96 | +12.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $23.4M | -65.0% |
| Current Assets | $212.6M | +1.0% |
| Total Assets | $252.0M | +2.0% |
| Current Liabilities | $20.5M | +32.9% |
| Total Liabilities | $27.9M | +12.5% |
| Stockholders' Equity | $224.1M | +0.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$85.7M | -14.0% |
| Capital Expenditures | $849K | -59.1% |
| Investing Cash Flow | -$43.4M | +60.3% |
| Financing Cash Flow | $85.7M | +239.6% |
| Free Cash Flow | -$86.5M | -12.1% |